A Sarcophagine Containing PSMA Ligand for Targeting Prostate Cancer with 64/67Cu

被引：0
|
作者：
Kelly, J. M. [1 ]
Ponnala, S. [1 ]
Nikolopoulou, A. [1 ]
Zia, N. [2 ]
Williams, C., Jr. [1 ]
Donnelly, P. S. [2 ]
Babich, J. W. [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-020
引用
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [31] Clinical application of Cu-64 PSMA PET/CT in Theranostics of prostate cancer
    Singh, Aviral
    Kulkarni, Harshad
    Klette, Ingo
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] The Feasibility of 64Cu-PSMA I&T PET for Prostate Cancer
    Lee, Chul-Hee
    Lim, Ilhan
    Woo, Sang-Keun
    Kim, Kwang Il
    Lee, Kyo Chul
    Song, Kanghyon
    Choi, Chang Woon
    Lim, Sang Moo
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (06) : 417 - 423
  • [33] New Production Routes for Medical Isotopes 64Cu and 67Cu Using Accelerator Neutrons
    Kin, Tadahiro
    Nagai, Yasuki
    Iwamoto, Nobuyuki
    Minato, Futoshi
    Iwamoto, Osamu
    Hatsukawa, Yuichi
    Segawa, Mariko
    Harada, Hideo
    Konno, Chikara
    Ochiai, Kentaro
    Takakura, Kosuke
    JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN, 2013, 82 (03)
  • [34] STUDIES WITH RADIOACTIVE COPPER (64CU AND 67CU) - ABDOMINAL SCINTISCANS IN PATIENTS WITH WILSONS DISEASE
    OSBORN, SB
    SZAZ, KF
    WALSHE, JM
    QUARTERLY JOURNAL OF MEDICINE, 1969, 38 (152): : 467 - +
  • [35] Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
    Nedrow, Jessie R.
    Latoche, Joseph D.
    Day, Kathryn E.
    Modi, Jalpa
    Ganguly, Tanushree
    Zeng, Dexing
    Kurland, Brenda F.
    Berkman, Clifford E.
    Anderson, Carolyn J.
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (03) : 402 - 410
  • [36] Targeting PSMA with a 64Cu-labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in a mouse model of prostate cancer
    Nedrow, Jessie
    Latoche, Joseph
    Day, Kathryn
    Ganguly, Tanushree
    Zeng, Dexing
    Berkman, Clifford
    Anderson, Carolyn
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [37] Mass production of 64, 67Cu using accelerator-based fast neutrons
    Kawabata, Masako
    Motomura, Arata
    Motoishi, Shoji
    Saeki, Hideya
    Ohta, Akio
    Nagai, Yasuki
    Ito, Masatoshi
    Tsukada, Kazuaki
    Hashimoto, Kazuyuki
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S283 - S283
  • [38] Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
    Jessie R. Nedrow
    Joseph D. Latoche
    Kathryn E. Day
    Jalpa Modi
    Tanushree Ganguly
    Dexing Zeng
    Brenda F. Kurland
    Clifford E. Berkman
    Carolyn J. Anderson
    Molecular Imaging and Biology, 2016, 18 : 402 - 410
  • [39] Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer
    Murce, Erika
    Spaan, Evelien
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S206 - S207
  • [40] Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
    Yvonne H. W. Derks
    Melline G. M. Schilham
    Mark Rijpkema
    Esther M. M. Smeets
    Helene I. V. Amatdjais-Groenen
    Annemarie Kip
    Sanne A. M. van Lith
    Jill van de Kamp
    J. P. Michiel Sedelaar
    Diederik M. Somford
    Michiel Simons
    Peter Laverman
    Martin Gotthardt
    Dennis W. P. M. Löwik
    Sandra Heskamp
    Susanne Lütje
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2872 - 2884
12345